Dr. Steven Smith leads National Institutes of Health-funded study to determine minocycline’s potential to address treatment-resistant hypertension

Dr. Steven Smith was awarded $3.3 million by the NIH to study the effects of the antibiotic minocycline on treatment-resistant hypertension.